Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash, cash equivalents, and restricted cash $ 90,556 $ 170,753
Commissions receivable 13,785 16,171
Prepaid expenses 7,546 8,813
Income tax receivable 9,461 9,299
Marketable debt securities, available-for-sale (amortized cost of $198,847 and $169,018 at March 31, 2024 and December 31, 2023, respectively, and $0 allowance for credit losses) 198,314 168,881
Advances and loans, net 7,861 3,574
Other assets, current 16,014 16,203
Total current assets 343,537 393,694
Property and equipment, net 27,832 27,450
Operating lease right-of-use assets, net 92,929 90,058
Marketable debt securities, available-for-sale (amortized cost of $59,302 and $69,538 at March 31, 2024 and December 31, 2023, respectively, and $0 allowance for credit losses) 57,400 67,459
Assets held in rabbi trust 11,467 10,838
Deferred tax assets, net 51,725 46,930
Goodwill and other intangible assets, net 50,041 51,183
Advances and loans, net 175,604 175,827
Other assets, non-current 16,116 14,972
Total assets 826,651 878,411
Current liabilities:    
Accounts payable and accrued expenses 9,359 8,126
Deferred compensation and commissions 40,511 55,769
Operating lease liabilities 17,535 18,336
Accrued bonuses and other employee related expenses 7,264 19,119
Other liabilities, current 17,923 3,919
Total current liabilities 92,592 105,269
Deferred compensation and commissions 27,304 47,771
Operating lease liabilities 73,935 69,407
Other liabilities, non-current 7,265 10,690
Total liabilities 201,096 233,137
Commitments and contingencies 0 0
Stockholders' equity:    
Preferred stock 0 0
Common stock 4 4
Additional paid-in capital 155,157 153,740
Retained earnings 471,670 492,298
Accumulated other comprehensive loss (1,276) (768)
Total stockholders’ equity 625,555 645,274
Total liabilities and stockholders’ equity $ 826,651 $ 878,411